Claritev Corp
CTEV
NYSE
Health Care
$32.59
USD
+5.75 (+21.42%)
At close: Aug 7, 2026, 4:00 PM EDT
Market Cap $445.46M
Volume 330.0K
About Claritev Corp
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 3,000 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
HQ
McLean, VIRGINIA, US
Founded
2020
Employees
3,000
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
4 metrics our research team weighs before forming a view on CTEV.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Gross Margin (TTM)
73.2%
—
Operating Margin (TTM)
4.3%
—
Net Margin (TTM)
-29.3%
—
Free Cash Flow (TTM)
$-35.90M
—
Financial Snapshot
Revenue
$978.76M
— YoY
Gross Margin
73%
TTM
— YoY
Net Income
$-286.52M
— YoY
Operating Cash Flow
$101.60M
— YoY
Key Statistics
Open
$29.14
Previous Close
$26.84
Day Range
$29.14 - $38.99
52 Week Range
$11.50 - $74.07
Volume
330.0K
Average Volume (10 Days)
80.0K
Dividend Yield
—
Valuation Measurement
Market Cap
$445.46M
P/E Ratio (TTM)
—
P/S Ratio (TTM)
0.46
Financial Highlights
Profit Margin
-29.3%
Return on Assets
-5.9%
Return on Equity
122.2%
Revenue (TTM)
$978.76M
Net Income (TTM)
$-286.52M
Diluted EPS (TTM)
-$17.33
Total Cash (MRQ)
$21.33M
Levered FCF (TTM)
$-35.90M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 05
Est. EPS
Adjusted consensus estimate
-$4.02
Analyst Consensus
Based on 1 analyst ratings
Avg Target: $32.00
(-1.8% upside)
High: $32.00 · Low: $32.00
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%